Scholars Central

Conference abstractPublished 12 Sep 2016

Restoring the regenerative capacity of human bone marrow-derived mesenchymal stem cells (BMMSCs) from the elderly to establish a high quality autologous MSC bank

Authors: Xiao-Dong Chen

University of Texas Health Science Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

MSC-based therapies have great potential for treating many age-related diseases. Due to biosafety concerns and FDA regulations, autologous stem cells are preferable for cell-based therapies. Unfortunately, the quantity and quality of MSCs decrease with aging, inhibiting progress in developing autologous MSC-based applications. In the present study, we propose an innovative approach for rescuing aged MSCs by separating a sub-population of more “youthful” cells, using biomarkers (size and SSEA-4 expression), from a population of cells obtained from the BM of elderly donors (human subjects); and protecting and amplifying this “youthful” sub-population by culture on a “young microenvironment” using our established patented technology (BM-ECM produced by young cells). The results demonstrate that by applying this approach we were able to identify and isolate a subpopulation of BM-MSCs from elderly donors, displaying a less “aged” phenotype, and culture them on a young microenvironment (BM-ECM) to significantly improve their proliferation and differentiation capacity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGenetics & Molecular Biology
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Xiao-Dong Chen”